BIOTECHNOLOGY in EUROPE and LATIN AMERICA Bernardo Sorj
Total Page:16
File Type:pdf, Size:1020Kb
BIBLIOTECA VIRTUAL DE CIÊNCIAS HUMANAS BIOTECH NOLOGY IN EUROPE AND LATIN AMERICA PROSPECTS FOR CO -OPERATION Bernardo Sorj Mark Cantley Karl Simpson Editors Biotechnology in Europe and Latin America prospects for co-operation Bernardo Sorj Mark Cantley Karl Simpson (eds.) SciELO Books / SciELO Livros / SciELO Libros SORJ, B., CANTLEY, M., and SIMPSON, K., eds. Biotechnology in Europe and Latin America: prospects for co-operation [online]. Rio de Janeiro: Centro Edelstein de Pesquisas Sociais, 2010. 219 p. ISBN: 978-85-7582-036-6. Available from SciELO Books <http://books.scielo.org>. All the contents of this chapter, except where otherwise noted, is licensed under a Creative Commons Attribution-Non Commercial-ShareAlike 3.0 Unported. Todo o conteúdo deste capítulo, exceto quando houver ressalva, é publicado sob a licença Creative Commons Atribuição - Uso Não Comercial - Partilha nos Mesmos Termos 3.0 Não adaptada. Todo el contenido de este capítulo, excepto donde se indique lo contrario, está bajo licencia de la licencia Creative Commons Reconocimento-NoComercial-CompartirIgual 3.0 Unported. Bernardo Sorj Mark Cantley Karl Simpson This publication is part of The Virtual Library of Social Sciences of The Edelstein Editors Center for Social Research - www.bvce.org Copyright © 2010, Mark Cantley, Karl Simpson, Bernardo Sorj Biotechnology in Europe Copyright © 2010 of this on-line edition: The Edelstein Center for Social Research and La tin America Prospects for co-operation No part of this publication may be reproduced or transmitted for commercial purposes in any form or by any means without permission in writing from the copyright holder at the address below. Parts of this publication may be reproduced for non commercial purposes so long as the authors and publisher are duly acknowledged. ISBN 978-85-7582-036-6 The Edelstein Center for Social Research http://www.centroedelstein.org.br/English/ Rua Visconde de Pirajá, 330/1205 Ipanema - Rio de Janeiro - RJ CEP: 22410-000. Brazil Contact: [email protected] Rio de Janeiro 2010 SUMMARY Preface ....................................................................................................... III 1.10. Spain ............................................................................................ 107 Armando Albert Welcoming Speech .......................................................................................1 Karl-Heinz Narjes 1.11. The United Kingdom ................................................................... 113 Roy Smither Remarks ........................................................................................................7 Phili Viehoff SECTION TWO – Biotechnology in Latin America ........................... 124 Comments ............................................................................................. 125 Introduction .................................................................................................9 Luis Ramiro Alfonsin Karl Simpson 2.0. Overview of Latin American Activities in Biotechnology ........... 129 Karl Simpson SECTION ONE – Biotechnology in Europe ...........................................21 1.0. Overview of European Activities in Biotechnology ........................22 2.1. Argentina ....................................................................................... 136 José La Torre and Sara B. de Rietti Karl Simpson 1.1. Belgium ............................................................................................29 2.2. Brazil ............................................................................................. 145 Antonio Paes de Carvalho Adapted from speech made by Mr C. de Wispelaere 1.2. Denmark ...........................................................................................37 2.3. Mexico ........................................................................................... 150 Rodolfo Quintero Ramirez and Rosa Luz Gonzalez Aguirre Bruno Hansen 1.3. France ...............................................................................................46 2.4. The Andean Countries .................................................................. 171 B. Carlos Aguirre Daniel Thomas 1.4. The Federal Republic of Germany ...................................................53 Health in the Third World: The Role of International Co-operation .... 205 Luiz Pereira da Silva Helmut Zeittrager 1.5. Greece ..............................................................................................68 Conclusions and Analysis ....................................................................... 211 Presentations by Drs Tzotzos and Dourtouglou Bernardo Sorj 1.6. The Republic of Ireland ....................................................................73 Brendan Finucane and Staff of BioResearch Ireland, Dublin 1.7. Italy ..................................................................................................81 Carmello Iacobello 1.8. The Netherlands ...............................................................................90 Henk C. van der Plas 1.9. Portugal ..........................................................................................100 Julio Novais I II PREFACE interests. Although inevitably any book on biotechnology is obsolete by the time it appears, there is nothing obsolescent about the dynamism now being displayed in the development of the bioindustries in both continents. We hope The accession of Spain and Portugal to membership of the that the presentations assembled in this volume will testify to this dynamic European Community in January 1985 not only brought new vitality to the development, and stimulate its further promotion. European initiative, but served as a powerful reminder of the broader The Editors, dimensions of the Spanish – and Portuguese-speaking worlds. A reinforcement of Europe’s natural and historical internationalism of Bernardo Sorj outlook was particularly relevant in the context of biotechnology; for the Mark Cantley sophisticated multi-disciplinary scientific base, and the several broad Karl Simpson application areas, force on biotechnology an internationalism both for access to scientific capability, and for access to worldwide markets. Such was the rationale for SOBELA ’: a Seminar on Biotechnology in Europe and Latin America’, which in April 1987 brought some 50 Latin American entrepreneurs, policy-makers and academic leaders to Europe and to Brussels. At the Commission’s Borschette Conference Centre, they heard presentations from eleven of the Community Member States, each emphasising its strengths in biotechnology and its interest in promoting industrial collaboration with firms in Latin America. The seminar was opened by speeches from Vice-President Karl- Heinz Narjes on behalf of the Commission, and by His Excellency Luis Ramiro Alfonsin of Argentina, senior Latin American diplomat in Brussels. In the closing session, Directors-General Paolo Fasella (Science, Research and Development, DG XII ) and Jean Durieux (External Relations, DG I ) welcomed Their Excellencies the ambassadors from Argentina, Mexico, Brazil, Uruguay and Colombia. The conference itself was preceded and followed by visits to the leading centers in the various Member States. The fruits of these exchanges were shown through more than a hundred proposals for industrial collaboration which resulted, many of them now converted into ongoing relationships. The Commission through its Directorate-General for External Relations is continuing to promote such collaboration, helping firms in each continent to find useful partners for trade, investment, technical collaboration or marketing. The materials presented at the conference have been updated and edited, to give in this book an up-to-date picture of capabilities and common III IV WELCOMING SPEECH transnational cooperation in research, and through training grants for researchers moving to laboratories outside their home country. Our current biotechnology research action programme runs until Karl-Heinz Narjes nineteen eighty-nine. It covers a wider range of subjects, including topics of importance to all the bioindustries, both in research , and in improving the Draft text of a speech by Vice-President Karl-Heinz Narjes , on 27 April infrastructure for research. We expect to expand the programme further in 1987 , at the opening session of the ‘Seminar on Biotechnology in Europe the near future. You will probably hear more about these activities during and Latin America’, Conference Centre Albert Borschette, Brussels. the course of the seminar. Your Excellency, Mr. Chairman, Ladies and Gentlemen, I should mention also that the breadth of biotechnology inevitably involves several other research areas, such as our agricultural research, our It gives me great pleasure to welcome, on behalf of the Commission, medical research, and (of particular relevance to this seminar), our the many distinguished visitors who have kindly accepted our invitation to programmes of science and technology for development . The first of these this international gathering. There are present, representatives of some programmes concerned tropical agriculture, health and nutrition. It ended in twenty different nations; but let me emphasise not our diversity, but our December 1986 ; and we hope shortly to finalise a substantially larger effort common interests. The European Community and its Member States have in the same areas, including a greater involvement of laboratories in worked together to organise